Patient groups (C9orf72 mutation carriers and sporadic patients) performed significantly worse at cognitive screening tests (MMSE and FTD-CDR-SOB) compared to HC but did not differ significantly from one another. The gene discussed is C9orf72; the disease is frontotemporal dementia.